Neoadjuvant therapy impact in early pancreatic cancer: "bioborderline" vs. "non-bioborderline".

Alvaro Gregorio Morales Taboada,Pablo Lozano Lominchar,María Fernández Martínez,Pilar García-Alfonso,Andrés Muñoz Martin,Jose Manuel Asencio

Annals of hepato-biliary-pancreatic surgery（2022）

引用 0|浏览7

暂无评分

摘要

A neoadjuvant strategy seemed to improve local control and the survival of patients with early pancreatic cancer, both those with elevated CA19-9 and normal marker levels.

查看译文

关键词

Biomarkers,Early pancreatic cancer,Neoadjuvant therapy,Pancreatic neoplasms

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要